Monocytes of allergics and non-allergics produce, store and release the neurotrophins NGF, BDNF and NT-3

Humboldt-Universität zu Berlin, Berlín, Berlin, Germany
Regulatory Peptides (Impact Factor: 1.83). 02/2005; 124(1-3):19-25. DOI: 10.1016/j.regpep.2004.06.024
Source: PubMed


Recent studies have shown that neurotrophins (NTs) are involved in inflammatory processes. Elevated plasma levels of NTs were found allergic diseases with the highest levels in allergic asthma. However, the exact cellular sources involved in the regulation and release of neurotrophins in allergic inflammation are still not well defined.
The aim of this study was to assess whether monocytes of allergic and non-allergic subjects produce, store and release the neurotrophins NGF, BDNF and NT-3.
Monocytes of allergic and non-allergic donors were purified by immunomagnetic selection. APAAP-staining for the presence of NTs and their receptors was performed. RT-PCR and Western blot evaluated the production and storage of NTs. Monocytes were incubated and supernatants were collected for measurement of neurotrophic factors after stimulation with lipopolysaccharide (LPS) as inflammatory stimulus. The neurotrophin content in lysates and cell culture supernatants was determined by ELISA.
Human monocytes express the neurotrophins NGF, BDNF and NT-3 but also their specific receptors TrkA, TrkB and TrkC. RT-PCR amplification of isolated mRNA demonstrated expression of the examined neurotrophins. Proteins were detectable by Western blot. NTs were found in the monocyte lysates and supernatants at different levels in allergic and non-allergic donors. Cell stimulation with LPS leads to release of NGF and NT3.
Monocytes, produce, store and release NGF, BDNF and NT-3. They are a possible source of elevated neurotrophin levels found in allergy and asthma.

9 Reads
  • Source
    • "As such, BDNF has access to all tissues and organs. Motile cells including activated T cells, B cells, and monocytes have been shown to express BDNF in vitro [8], [9], as have eosinophils [10], dendritic cells [11], and endothelial cells [12]. In mice, the visceral epithelium [13], and airway epithelium are significant sources of BDNF [14]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The neurotrophins are neuropeptides that are potent regulators of neurite growth and survival. Although mainly studied in the brain and nervous system, recent reports have shown that neurotrophins are expressed in multiple target tissues and cell types throughout the body. Additionally, dysregulation of neurotrophins has been linked to several disease conditions including Alzheimer's, Parkinson's, Huntington's, psychiatric disorders, and cancer. Brain derived neurotrophic factor (BDNF) is a member of the neurotrophin family that elicits its actions through the neurotrophic tyrosine receptor kinase type 2 (Ntrk2). Together BDNF and Ntrk2 are capable of activating the adhesion, angiogenesis, apoptosis, and proliferation pathways. These pathways are prominently involved in reproductive physiology, yet a cross-species examination of BDNF and Ntrk2 expression in the mammalian uterus is lacking. Herein we demonstrated the conserved nature of BDNF and Ntrk2 across several mammalian species by mRNA and protein sequence alignment, isolated BDNF and Ntrk2 transcripts in the uterus by Real-Time PCR, localized both proteins to the glandular and luminal epithelium, vascular smooth muscle, and myometrium of the uterus, determined that the major isoforms expressed in the human endometrium were pro-BDNF, and truncated Ntrk2, and finally demonstrated antibody specificity. Our findings suggest that BDNF and Ntrk2 are transcribed, translated, and conserved across mammalian species including human, mouse, rat, pig, horse, and the bat.
    PLoS ONE 04/2014; 9(4):e94036. DOI:10.1371/journal.pone.0094036 · 3.23 Impact Factor
  • Source
    • "In future, conditionally gene-targeted systems may be of help to answer the question of the functional role of SOCS-3 in COPD and modern techniques such as laser-assisted single/oligo cell analysis [55] may further dissect the impaired SOCS signaling pathway on the cellular level. This should be combined with molecular biology [55,56], histo-/cytochemistry [57-59] and pharmacological [12,35,60] techniques. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Tobacco is a leading environmental factor in the initiation of respiratory diseases and causes chronic obstructive pulmonary disease (COPD). Suppressor of cytokine signaling (SOCS) family members are involved in the pathogenesis of many inflammatory diseases and SOCS-3 has been shown to play an important role in the regulation, onset and maintenance of airway allergic inflammation indicating that SOCS-3 displays a potential therapeutic target for anti-inflammatory respiratory drugs development. Since chronic obstructive pulmonary disease (COPD) is also characterized by inflammatory changes and airflow limitation, the present study assessed the transcriptional expression of SOCS-3 in COPD. Real-time PCR was performed to assess quantitative changes in bronchial biopsies of COPD patients in comparison to unaffected controls. SOCS-3 was significantly down-regulated in COPD at the transcriptional level while SOCS-4 and SOCS-5 displayed no change. It can be concluded that the presently observed inhibition of SOCS-3 mRNA expression may be related to the dysbalance of cytokine signaling observed in COPD.
    Journal of Occupational Medicine and Toxicology 10/2013; 8(1):29. DOI:10.1186/1745-6673-8-29 · 1.62 Impact Factor
  • Source
    • "Thus, BDNF and other neurotrophins have two functions: to protect the brain neurons from inflammatory events [91] [92] and in the respiratory tract, peripheral nerves, and urinary bladder may function as proinflammatory molecules [93] [94] [95]. It is noteworthy that BDNF is present not only in brain neurons but also in several other tissues such as salivary glands, stomach , duodenum, ileum, colon, lung, heart, liver, pancreas, kidney, oviduct, uterus, bladder, and monocytes and eosinophils [96] [97] [98]. BDNF is involved in other inflammatory diseases such as rheumatologic conditions [99] [100] [101], myocardial injury in the aging heart [102], inflammatory bowel disease [103] [104], atopic dermatitis [105], and other conditions. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Obesity, which is assuming alarming proportions, has been attributed to genetic factors, hypothalamic dysfunction, and intestinal gut bacteria and an increase in the consumption of energy-dense food. Obesity predisposes to the development of type 2 diabetes mellitus, hypertension, coronary heart disease, and certain forms of cancer. Recent studies have shown that the intestinal bacteria in obese humans and mice differ from those in lean that could trigger a low-grade systemic inflammation. Consumption of a calorie-dense diet that initiates and perpetuates obesity could be due to failure of homeostatic mechanisms that regulate appetite, food consumption, and energy balance. Hypothalamic factors that regulate energy needs of the body, control appetite and satiety, and gut bacteria that participate in food digestion play a critical role in the onset of obesity. Incretins, cholecystokinin, brain-derived neurotrophic factor, leptin, long-chain fatty acid coenzyme A, endocannabinoids and vagal neurotransmitter acetylcholine play a role in the regulation of energy intake, glucose homeostasis, insulin secretion, and pathobiology of obesity and type 2 diabetes mellitus. Thus, there is a cross-talk among the gut, liver, pancreas, adipose tissue, and hypothalamus. Based on these evidences, it is clear that management of obesity needs a multifactorial approach.
    Nutrition 12/2009; 26(5):459-73. DOI:10.1016/j.nut.2009.09.020 · 2.93 Impact Factor
Show more